The FDA conducted 55 inspections at biologics firms in Pennsylvania during 2025, according to the U.S. Food and Drug Administration (FDA).
These inspections represented the third lowest count among different company types inspected by the FDA in Pennsylvania, accounting for 9.5% of all inspections that year.
Among Pennsylvania’s biologics companies, A Plus Phlebotomy Services received the highest number of FDA citations in 2025.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 44 | 5 | — |
| Blood and Blood Products | 26 | 5 | — |
| Compliance: Devices | 21 | 7 | 1 |
| Drug Quality Assurance | 14 | 22 | 6 |
| Food Composition, Standards, Labeling and Econ | 86 | 3 | 1 |
| Foodborne Biological Hazards | 262 | 45 | 1 |
| Human Cellular, Tissue, and Gene Therapies | 14 | 2 | — |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 47 | 27 | — |
| Postmarket Assurance: Devices | 7 | 3 | — |
| Technical Assistance: Food and Cosmetics | 26 | 1 | — |
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
